abstract |
COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND. Compounds that act as potent CCR1 receptor antagonists and have antiinflammatory activity in vivo are provided. The compounds are generally derived from aryl piperazine and are useful in pharmaceutical compositions, methods for treating CCR1 mediated diseases and as assay controls for the identification of competitive CCR1 antagonists. |